• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapyChristos Andronis2020-08-03T13:49:12+00:00
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit.

Explore the live graph.

Tags: ABATACEPT, CANCER, CTLA4, CYTOKINE PRODUCTION, IMMUNE RESPONSE, IPILIMUMAB, LYMPHOCYTE ACTIVATION, MELANOMA, NIVOLUMAB, PD-1, PEMBROLIZUMAB, PROGRAMMED CELL DEATH, REGULATORY T-LYMPHOCYTES, T CELL ACTIVATION

Post navigation

← Circadian rhythm genes
Drugs for Parkinson’s and Alzheimer’s →

Vizit Graphs Tag Cloud

SARS-COV-2 CELL DIFFERENTIATION ALZHEIMER'S DISEASE TNF ALBUMIN INFLAMMATORY RESPONSE NFKB1 CELL PROLIFERATION ACE APOPTOTIC PROCESS PD-1 COAGULATION PARKINSON DISEASE IL2 AUTOPHAGY COVID-19 IMMUNE RESPONSE HELICOBACTER PYLORI TMPRSS2 NEUTROPHILS IL1B AGING INTERFERON CD4 ANGIOTENSIN II INFLAMMATION RAS MYALGIA IL6 RHEUMATOID ARTHRITIS IL10 ESCHERICHIA COLI LISTERIA MONOCYTOGENES PSEUDOMONAS AERUGINOSA METFORMIN CANDIDA ALBICANS IMMUNITY LACTATE DEHYDROGENASE STAPHYLOCOCCUS AUREUS ACE2 CASP3 COGNITION INSULIN CANCER IFNG

© 2021 Biovista Vizit All Rights Reserved.